Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

SNPHF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.18B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.16.91.97%13%-0.1
$13.29

Current Fair Value

2.1% upside

Undervalued by 2.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.18 Billion
Enterprise Value$-41,399,460,256.00
Annual dividend$0.25
Dividend yield1.97%
Earnings per Share$115.04
Beta0.24
Outstanding Shares321,640,257

Return

Return on Equity12.79%ROE
Return on Assets9.30%
Return on Invested Capital13.77%

Valuation & Multiples

P/E Ratio16.91P/E Ratio
PEG1819.88PEG
Price to Sales0.01Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue2.05
Enterprise Value to EBIT12.89
Enterprise Value to Net Income-2
Total Debt to Enterprise0.06
Debt to Equity0.12Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS
$0.16
Est. $0.20
Revenue
$472.23 M
Est. $462.47 M

Next Earnings Call

Expected Date
February 9, 2027
EPS Estimate
$0.24
Consensus analyst estimate
Revenue Estimate
$484.12 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Santen Pharmaceutical Co., Ltd.

3,968 employees
CEO: Takeshi Ito

Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addr...